Stream 6: Clinical Diabetes Management and Therapeutics #18 - Late Breaking Abstracts

Tracks
Meeting Room 101 & 102
Friday, August 21, 2026
4:00 PM - 6:00 PM

Speaker

Agenda Item Image
Prof Elif Ekinci
Head, Department of Medicine, Melbourne Medical School, The University of Melbourne
University of Melbourne

Phase 3 trial of Survodutide once weekly for the treatment of adults with obesity: SYNCHRONIZE™-1

4:00 PM - 4:15 PM

Abstract

Biography

Professor Elif Ekinci is Head of the Department of Medicine at the University of Melbourne and Director of ACADI. An internationally recognised clinician scientist in endocrinology, her work focuses on diabetes, diabetes complications, obesity and metabolic disease, translating research into models of care that improve access, outcomes and patient experience
Marie Sinclair
Clinical Associate Professor
Victorian Liver Transplant Unit / Austin Health

Phase 3 trial of survodutide in adults with obesity and MASLD

4:15 PM - 4:30 PM

Abstract

Biography

Dr Marie Sinclair is an Associate Professor at the University of Melbourne and a transplant hepatologist at Austin Health, Australia. Her research focuses on obesity, MASLD, sarcopenia, and nutrition in advanced liver disease, with extensive experience in multicentre clinical trials and translational hepatology research.
Agenda Item Image
Prof John Wentworth
Endocrinologist and Senior Clinical Researcher
Royal Melbourne Hospital / St Vincent's Institute of Medical Research

Improved beta cell function following a single dose of human antithymocyte globulinin type 1 diabetes : results of an Australian phase 1 clinical trial.

4:30 PM - 4:45 PM

Abstract

Biography

John is a clinician-scientist whose research focuses on the prediction and prevention of type 1 diabetes.
Agenda Item Image
Dr Yee Wen Kong
Endocrinologist
Diabetes Technology Research Group

Clinical insights into sodium-glucose cotransporter 2 inhibitor therapy and continuous ketone monitors in Type 1 diabetes from the PARTNER trial

4:45 PM - 5:00 PM

Abstract

Biography

Dr Yee Wen Kong is an endocrinologist with a strong interest in type 1 diabetes and diabetes technology research. She is pursuing a PhD, focusing on ketone monitoring technology and use to SGLT2 inhibitors in type 1 diabetes.
Agenda Item Image
Dr Aniket Nadkarni
Intensive Care Specialist
Adelaide University

GLP-1 Is not superior to insulin for glycaemic control during stress hyperglycaemia

5:00 PM - 5:15 PM

Abstract

Biography

Dr Aniket Nadkarni is an intensive care specialist at the Austin Hospital, Melbourne, and is a PhD candidate at Adelaide University, with a thesis titled "Mitigating the short and long term complications of stress-induced hyperglycaemia". His research interests including glycaemic control in the critically ill, neurocritical care, and iatrogenic anaemia.
Shuyi Yu
Beijing
Beijing Hospital

Construction of a predictive model for insulin-related latent adipose hyperplasia based on clinical data and injection behavior characteristics

5:15 PM - 5:30 PM

Abstract

Biography

Yu Shuyi¹,²; Wang Yunyu¹,²; Wang Weihao¹,²; Liu Zhiwen²,³; Wu Quanying²,⁴,*¹ Department of Endocrinology, Beijing Hospital, Beijing 100730;² National Center for Geriatric Medicine, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730;³ Department of Ultrasound, Beijing Hospital, Beijing 100730;⁴ Nursing Department, Beijing Hospital, Beijing 100730
Dr Rama Walia
Additional Professor
PGIMER Chandigarh

A proof-of-concept study of type 2 diabetes remission with pharmacotherapy.

5:30 PM - 5:45 PM

Abstract

Biography

Dr. Rama Walia is an additional professor in the Department of Endocrinology at the Postgraduate Institute of Medical Education and Research, Chandigarh. Her research focuses on endocrinology, puberty and fertility disorders, diabetes, and metabolic diseases. She has contributed extensively to clinical research and published widely in reputed international journals.
loading